Helix BioMedix Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Robin Carmichael

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure14.2yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Robin Carmichael (66 yo)

9.3yrs

Tenure

US$304,350

Compensation

Ms. Robin L. Carmichael has been the Chief Executive Officer of Helix Biomedix Inc. since July 10, 2017 and its President since February 2015 and served as its Chief Operating Officer since January 12, 201...


Board Members

NamePositionTenureCompensationOwnership
Robin Carmichael
Presidentno dataUS$304.35kno data
John Clifford
Director16.8yrsUS$21.80kno data
R. Beatty
Chairman of the Board25yrsUS$414.35kno data
Richard Cohen
Director18.4yrsUS$23.60kno data
William Goolsbee
Director4.6yrsno datano data
Lawrence Jones
Director14.2yrsUS$21.30kno data
Stephen Lloyd
Member of Scientific Advisory Board4.3yrsno datano data
Amanda McCullough
Member of Scientific Advisory Board4.3yrsno datano data

14.2yrs

Average Tenure

72yo

Average Age

Experienced Board: HXBM's board of directors are seasoned and experienced ( 14.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.